Your search returned 5 results.

Results
	1.	Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors: Ratner, Robert E PMID: 24650952 Year: 2014 Citation: Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T DOI: http://dx.doi.org/10.1016/j.jdiacomp.2014.01.012 Add to cart (remove)
	2.	Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors: Aroda, Vanita R PMID: 26990378 Year: 2016 Citation: Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J DOI: https://dx.doi.org/10.1111/dom.12661 Add to cart (remove)
	3.	Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors: Fatemi, Omid Yuriditsky, Eugene PMID: 25159234 Citation: American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15. Institution: MedStar Heart & Vascular Institute Medline publication type: Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E DOI: http://dx.doi.org/10.1016/j.amjcard.2014.07.045 Add to cart (remove)
	4.	Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors: Weissman, Neil J PMID: 22421927 Year: 2012 Citation: Obesity. 20(7):1426-36, 2012 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J DOI: http://dx.doi.org/10.1038/oby.2012.66 Add to cart (remove)
	5.	Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors: Ratner, Robert E PMID: 23175674 Year: 2013 Citation: Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb. Institution: MedStar Health Research Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Form of publication: Journal Article All authors: Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D DOI: http://dx.doi.org/10.1161/ATVBAHA.112.300346 Add to cart (remove)

Powered by Koha